Fibrobiologics, Inc. · NASDAQ:FBLG
Fibrobiologics, Inc. shareholders
As of Jun 30, 2026, 15 institutions reported holding Fibrobiologics, Inc., 4.3% of its shares. Largest: Cascade Financial Partners, LLC, Fund Evaluation Group, LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Fibrobiologics, Inc. | Change | Filed |
|---|---|---|---|---|
| Cascade Financial Partners, LLC | 109K | 1.6% | +92,400 | Aug 4, 2026 |
| Fund Evaluation Group, LLC | 51,794 | 0.78% | no change | Aug 7, 2026 |
| Vanguard | 34,149 | 0.51% | −39,896 | Aug 13, 2026 |
| Geode Capital | 30,299 | 0.46% | +690 | Aug 12, 2026 |
| Qube Research & Technologies Ltd | 24,313 | 0.37% | new | Aug 14, 2026 |
| BlackRock | 18,238 | 0.27% | −6,409 | Aug 7, 2026 |
| Barclays | 7,243 | 0.11% | new | Aug 14, 2026 |
| Tower Research Capital LLC (TRC) | 4,728 | 0.07% | +4,268 | Aug 11, 2026 |
| Osaic Holdings, Inc. | 2,404 | 0.04% | +2,250 | Aug 14, 2026 |
| RBC | 1,522 | 0.02% | +1,336 | Aug 14, 2026 |